Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Blocking Interfering Microbes: Irinotecan is a widely used anticancer pro-drug that is converted in the liver into the active form, but when it gets into the gut, the normally benign microbial flora can convert it into the toxic form, which kills the rapidly multiplying gut epithelium as it would kill rapidly dividing tumor cells, and thus causes diarrhea. Wallace et al. (p. 831 ; see the Perspective by Patel and Kaufmann ) used high-throughput screening to identify inhibitors that target the offending bacterial enzyme, β-glucuronidase, without killing the bacteria or affecting orthologous mammalian enzymes. Crystal structures revealed the molecular basis of selectivity, and in vivo studies showed that an inhibitor protected mice from irinotecan-induced toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Taken together, this functional metabolic repertoire includes the capacity for clinically relevant activation (e.g., sulfasalazine) (Peppercorn and Goldman, 1972b), reactivation (e.g., irinotecan/SN-38) (Wallace et al., 2010), and detoxification (e.g., digoxin) (Haiser et al., 2013) of xenobiotics with broad implications for drug action and toxicity (see Table 1).”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Wallace et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“Toxic or adverse consequences can also ensue, as is the case for irinotecan (Wallace et al., 2010)”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Wallace et al., 2010
In the citing paper
“Notably, β-glucuronidase inhibitors are capable of rescuing mice from drug toxicity.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [146]
In the citing paper
“This specificity towards the bacterial enzymes was revealed with the assistance of crystallography and bioinformatics, which demonstrated that these inhibitors interacted with a “bacterial loop” that is highly conserved and well distributed across the gut bacteria enzymes, but is absent from the mammalian enzyme146.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [146]
In the citing paper
“The answer appears to be yes for the bacterial β-glucuronidases, for which multiple inhibitors now exist that have minimal impact on the mammalian homolog143–146.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [146]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007) · Nature · doi:10.1038/nature06244 · Cited by 6,091
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
CDD: specific functional annotation with the Conserved Domain Database
Marchler-Bauer, A., Anderson, J. B., Chitsaz, F., Derbyshire, M. K., DeWeese-Scott, C., Fong, J. H., Geer, L. Y., Geer, R. C., Gonzales, N. R., Gwadz, M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn845 · Cited by 1,071
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
Mathijssen, R. H. J., van Alphen, R. J., Verweij, J., Loos, W. J., Nooter, K., Stoter, G., & Sparreboom, A. (2001) · PubMed · Cited by 740
Three-dimensional structure of β-galactosidase from E. coli.
Jacobson, R. H., Zhang, X.-J., DuBose, R. F., & Matthews, B. W. (1994) · Nature · doi:10.1038/369761a0 · Cited by 600
Research works printed but not linked: 4
- Mathijssen RHJ Clin Cancer Res 7 2182 2001 11489791
- Basińska A Floriańczyk B Ann Univ Mariae Curie Sklodowska Med 58 386 2003 15323223
- Jain S Nat Struct Mol Biol 3 375 1996 · DOI · Paper page
- Brattain MG Fine WD Khaled FM Thompson J Brattain DE Cancer Res 41 1751 1981 7214343
Cited by
Items 901–1,000 of 1,001
Inhibitory effect of 4-ethylcatechol on β-glucuronidase activity
Kuji, M., Itoh, N., Ohba, Y., Yamada, K., & Hashimoto, K. (2021) · Food Science and Technology Research · doi:10.3136/fstr.27.797 · Cited by 3
Next-generation microbial drugs developed from microbiome's natural products
Bhattarai, K., Bhattarai, K., & Baral, B. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.007 · Cited by 2
The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies
Pederzoli, F., Murdica, V., Salonia, A., & Alfano, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80546-3_19 · Cited by 2
Modulation of human microbiome and drug metabolism
Shahid, A., Hayat, S., Munir, S., Ashfaq, U. A., Khan, A. A., Bilal, M., Shaukat, I., & Khurshid, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95120-3.00012-9 · Cited by 2
Check your microbiota when taking the drug
Hochrath, K., & Schnabl, B. (2017) · Hepatology · doi:10.1002/hep.29422 · Cited by 2
Farhangfar, A. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3w13d · Cited by 2
Drug Metabolism Synthetic (Phase II) Reactions
Talevi, A., & Bellera, C. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_64-1 · Cited by 2
Chambers, L., Esakov, E. L., Braley, C., Trestan, L., Alali, Z., Bayık, D., Lathia, J. D., Sangwan, N., Bazeley, P. S., Joehlin-Price, A. S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-80626/v2 · Cited by 2
An Overview of the Dichotomous Role of Microbiota in Cancer Progression and Management
Jain, P., Mohapatra, S., Farooq, U., Hassan, N., Mirza, M. A., & Iqbal, Z. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096282503240124104029 · Cited by 2
Building a Better Microbiome: Advances in Microbiome Engineering for Human Health
Munir, S., Aslam, S., Imran, M., Ashfaq, U. A., Ejaz, H., Taqveem, A., & Khurshid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_20 · Cited by 1
Shen, J., Zhao, Q., Zhang, K., Zhang, J., & Zhang, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106510 · Cited by 1
β-Glucuronidase Acts as a Novel Nonantioxidative Target for Vitamin E
Li, W., Ling Zhi, X. I. A. O., Qi, J., Zhang, Y., Huang, Z., & Zhu, L. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c03447 · Cited by 1
Decoding the Influence of Gut Microbial Enzymes on Drug Metabolism: Insights and Strategies
Palanisamy, H., & Vidyalakshmi, S. (2025) · Biology Bulletin Reviews · doi:10.1134/s2079086425600419 · Cited by 2
Li, G., Hou, Y., Zhang, L., Chen, L., Yang, Y., & Yu, D. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04432-3 · Cited by 1
Pacheco-Barcía, V., Méndez, A. M., Hernández-Jiménez, E., Jiménez‐Fonseca, P., Martín, A. J. M., Custodio‐Cabello, S., Palka-Kotlowska, M., Gonzalez-Diaz, I., & Cabezón‐Gutiérrez, L. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.107877 · Cited by 1
Zhao, Z., Li, Q. X., Bai, X., Zhai, E., Dai, W., Yan, Q., Zhang, T., Huang, Z., Huang, Z., Meng, F., et al. (2025) · Advanced Science · doi:10.1002/advs.202517747 · Cited by 1
Wu, Y. C., 曹晓艳, Yu, L., Yao, J., Sun, C., Ruan, J., Wang, D., Zhang, Y., & Wang, T. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1648107 · Cited by 1
Host diets drive microbiome evolution and functional divergence
Nguyen, K. L., Xia, J. S., & Mei, W. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102068 · Cited by 1
Species-specific deglucuronidation of quercetin glucuronides by the human gut microbiota
Sultana, M. J., Yoshida, Y., Kurihara, S., Nishikawa, M., & Ikushiro, S. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag032 · Cited by 1
A Comprehensive Review of Diet and Gut Microbiome on Oral Drug Absorption and Efficacy
Thakur, S. (2026) · TMP Universal Journal of Research and Review Archives. · doi:10.69557/ujrra.v5i1.251 · Cited by 1
Wray, C., Castañeda-Monsalve, V., Engelmann, B., Rolle-Kampczyk, U. E., Schweiger, N., Gutsfeld, S., Ghosh, D., Kader, S., Tyler, C. R., Jehmlich, N., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag022 · Cited by 1
Joshi, D., Chauhan, K., Oberoi, H. S., Kumar, D., & Taneja, N. K. (2026) · Discover Biotechnology · doi:10.1007/s44340-026-00053-2 · Cited by 2
The role of gut microbiota in obesity-related cancers
Shi, W., Song, B., Xia, S., & Jia, D. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.04.002 · Cited by 1
The Complex Interplay between Botanical Supplements and the Human Gut Microbiome
Ponte, A. T., Liu, A., Acquah, K. S., & Balunas, M. J. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c01493 · Cited by 1
Le, H. T. T., Le, H. X., Huyen, D. T., Tran, T.-A., Quyền, Đ. V., Song, L. H., Tran, T. V., Thas, O., Nhung, P. H., & Tran, T. T. T. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i18.118267 · Cited by 1
Łysiak, J., Abdulgater, A., Stępień, G., Przewoźna, U., Urowska, W., Osuch-Tomaszewska, P., Kossmann, M., Szalewska, L., Burtowicz, J., & Kazubek-Fuksiewicz, I. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5462 · Cited by 1
In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole
Sugiyama, K., Satô, K., Aoki, H., KOTORI, M., Nakano, R., Hida, N., Kusano, M., & Akiyama, M. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00869-z · Cited by 1
Gut microbial metabolism of Flutamide attenuates its therapeutic efficacy against prostate cancer
Li, S., Ding, H., Wang, J., Yuan, L., Zhou, Y., Xu, W., Yin, H., Ye, M., Sha, Y., Li, F., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2682803 · Cited by 1
Nagao, I., & Kim, H. J. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-026-00099-1 · Cited by 1
Araújo, G., Domingues, S., Silva, G., & Lima, T. (2026) · Metabolites · doi:10.3390/metabo16090602 · Cited by 1
Zhao, Y., Peng, C., Xia, Y., Dong, T., Xu, J., Shan, X., Zhong, X., Xue, J., Bing, Z., Li, P., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.09.003 · Cited by 1
Schlachter, C. R., McGee, A. C., Sitasuwan, P., Horvath, G. C., Karri, N. G., Lee, L. A., & Tomashek, J. J. (2021) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109742 · Cited by 1
Francescone, R., & Costa, D. B. V. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch25 · Cited by 1
Biotransformation by the Gut Microbiome
Chi, L., & Lü, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64268-x · Cited by 1
The role of model animals in the study of symbiotic microorganisms
Yaqian, X., Chuan, L., Xiao, L., & BGI-Shenzhen, S. (2019) · Biodiversity Science · doi:10.17520/biods.2019042 · Cited by 1
Safety profile of pharmacotherapy in paitionts with non-alcogolic fatty liver disease
Peresada, E., Seliverstov, P. V., Вавилова, Т. В., Башарин, В. А., & Радченко, В. Г. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-3-69-75 · Cited by 1
Pharmaceutical significance and recent developments in utilizing bacterial enzymes
Vulichi, S. R., Kumar, R., Chippada, A. R., Sistla, D. S. M., Chunduri, V. R., Kapur, S., & Galla, K. M. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821406-0.00009-6 · Cited by 1
Microbiome for Personalized Medicine
Rathi, P., Verma, D., Singh, A. K., & Garg, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-8562-3_7 · Cited by 1
Analysis of the intestinal microbiome in colorectal cancer
Ильгизович, Г. Б., Гатауллин, И. Г., Nga, N. T., Kolpakov, A. I., & Ilinskaya, O. N. (2021) · Kazan medical journal · doi:10.17816/kmj2021-185 · Cited by 1
Microbial metabolites in nutrition and healthcare
Sundar, K., & Prabu, T. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824523-1.00012-2 · Cited by 1
(2010) · Nature reviews. Cancer · doi:10.1038/nrc2977 · Cited by 1
LEVERAGING SMALL MOLECULES TO MODULATE THE MICROBIOME TO TREAT HUMAN DISEASES
Gulati, A., & Guo, X. (2022) · Medicinal chemistry reviews · doi:10.1021/mc-2022-vol57.ch16 · Cited by 1
The changes of gut microbiota and metabolites in different drug-induced liver injuries
Zhu, R., Gao, Y., Dong, J., Li, Z., & Ren, Z. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001778 · Cited by 1
Interaction of the Gut Microbiome With Cancer Treatment
Barrenechea, P. M. (2024) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2024.15.5.3 · Cited by 1
Liu, Y., Li, X., Cheng, R., Wang, C., Dai, D., & Li, C. (2025) · ACS Agricultural Science & Technology · doi:10.1021/acsagscitech.4c00477 · Cited by 1
UNDERSTANDING DRUG METABOLISM IN HUMANS
Weidolf, L. O. G., & Wilson, I. D. (2016) · Wiley eBooks · doi:10.1002/9781118949689.ch6 · Cited by 1
Yan, A. (2015) · MacSphere (McMaster University) · doi:10.71548/4409 · Cited by 2
Proteobacteria drive significant functional variability in the human gut microbiomePreprint
Bradley, P. H., & Pollard, K. S. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/056614 · Cited by 1
Gut bacteria can stop cancer drugs from working
Reardon, S. (2017) · Nature · doi:10.1038/nature.2017.22109 · Cited by 1
Agents Which Act Directly on DNA
Todd, A., Groundwater, P. W., & Gill, J. H. (2017) · Wiley eBooks · doi:10.1002/9781118696194.ch2.1 · Cited by 1
Crawford, J. M. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731185202.793538117 · Cited by 1
Su, J., Dong, J., Kitaguchi, T., Ohmuro‐Matsuyama, Y., & Ueda, H. (2018) · The Analyst · doi:10.1039/c8an90057d · Cited by 1
Tiwari, S. (2014) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Boelsterli, U. A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12102
Conformational Analysis of Disordered Proteins Using H/D Exchange Mass Spectrometry
Keppel, T. R. (2013) · KU ScholarWorks (The University of Kansas)
Safarov, N. A., & Gasanov, R. A. (2015) · International Journal of Pharmaceutical Chemistry · doi:10.7439/ijpc.v5i11.2742
Metagenomic systems biology: frameworks for modeling and characterizing the gut microbiome
Greenblum, S. I. (2014) · ResearchWorks at the University of Washington (University of Washington)
Towards in vivo editing of the human microbiome
Yaung, S. J. (2015) · DSpace@MIT (Massachusetts Institute of Technology)
Morgan, X. C., & Huttenhower, C. (2014)
DRUG USE AND AGE ALTERS THE DRUG METABOLISM POTENTIAL OF THE HUMAN GUT MICROBIOME
LeBlanc, T. (2016) · DalSpace (Dalhousie University)
Shaping cancerous landscapes with microbial communities
Kulkarni, A. (2016) · Postdoc Journal · doi:10.14304/surya.jpr.v4n11.5
Ritter, A. D. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2p30c
Drug Targeting of the Human Microbiome
Ling, H., Foo, J. L., Saxena, G., Swarup, S., & Chang, M. W. (2017) · Wiley eBooks · doi:10.1002/9783527696130.ch7 · Cited by 1
Uterine Fibroids (Leiomyomata)
Warshowsky, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00058-x
Carron, C. (2017) · theses.fr (ABES) · doi:10.70675/72a87c16z1d03z481azbcb1z6ca28c3c050c · Cited by 1
Probe for the Personalized Glucuronide Prodrug Targeted Therapy
Su, Y.-C., Cheng, T.-C., Leu, Y.-L., Roffler, S. R., Chuang, C.-H., Kao, C.-H., Chen, K., Wang, H., & Cheng, T. (2014)
Self-citationIntestinal permeability as a marker of gastrointestinal health
Forsgård, R. A. (2018) · Työväentutkimus Vuosikirja
A mechanism based approach for screening metagenomic libraries for unusual glycosidases
Nasseri, S. A. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0364579
Up‐close‐and‐personal with the human microbiome
Berry, D. (2018) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12709
The Microbiota and Ovarian Cancer
Tanyi, J. L., & Facciabene, A. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_11
Exploring the Role of the Microbiome in Breast Carcinogenesis
Boncales, J. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/eswk-b311
Taylor, M. R. (2018) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/32883
Nutrition, the Gastrointestinal Microbiota and Cancer Prevention
Lopes, R. G., do Prado, S. B. R., & Fabi, J. P. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016506-00261
Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom
Maier, L. (2019) · BIOspektrum · doi:10.1007/s12268-019-1302-9
Analyzing Multigene Stacking and Genome Editing Strategies in Rice
Pathak, B. P. (2019) · Journal of the Arkansas Academy of Science
Beta-Glucuronidase System, Intestinal Microflora, and Genesis of Colorectal Tumors
Al-Hemiri, A., Aigazally, M., Novochadov, V. V., & Korchagina, A. (2020) · Natural Systems and Resources · doi:10.15688/nsr.jvolsu.2019.4.5
Kittakoop, P. (2021) · Biochemistry · doi:10.5772/intechopen.92840 · Cited by 1
Pharmacogenetics and personalized medicine
Núñez‐Torres, R., & González‐Neira, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00010-7
Yang, F. (2020) · Human Biology
Therapeutic role and importance of gut microbiota in brain and related disorder: A review
Kundu Smita, S., & Rana, D. G. (2021) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2021.7.1.6
Zhang, C. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/85829
Comprehensive Gut Microbiota and Drug Processing
Selber‐Hnatiw, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00104-2
Barrett, M. (2021) · Cork Open Research Archive (University College Cork, Ireland)
Gut Microbiota: The Servant of Human Being and the Accessary of Tumorigenesis
Gu, P., Li, D., Xu, G., Sun, Y., & Wu, M. (2020) · Trends in Oncology · doi:10.37155/2717-5278-0301-5
Hanson, P. (1983) · PubMed Central
Pharmacogenomics of Anti-Cancer Drugs
Carr, D. F., Turner, R. M., & Pirmohamed, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00159-6
Issues in Laboratory Animal Science That Impact Toxicologic Pathology
Everitt, J. I., King-Herbert, A. P., Clements, P., & Adler, R. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00006-6
Aarnoutse, R. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211203ra
Current Knowledge About the Implication of Bacterial Microbiota in Human Health and Disease
Nikolova, D. N. (2021) · Acta Medica Bulgarica · doi:10.2478/amb-2021-0047
An Impressive End to a Distinguished Career
Fox, B. A., Schaeffer, B. S., & Connelly, J. E. (2006)
Excitation of the 4 1 S Level of Helium by Hydrogen Impact
Crothers, D. S. F. (1968)
The role of diet and physical activity in influencing the microbiota/microbiome
Murphy, E. A., & Velázquez, K. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00017-x · Cited by 1
Biological significance of gut microbiota changes associated with ageing
Horgan, K., Shanahan, F., & O’Toole, P. W. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0047
Pharmacology: Blocking a gut reaction
(2010) · Nature · doi:10.1038/468348d
Uterine Fibroids (Leiomyomata)
Warshowsky, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00108-4
(2010) · Nachrichten aus der Chemie · doi:10.1002/nadc.201178182
Cotter, P. D., & Barton, W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726708065.793567416
Metadata
- Authors
- Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., & Redinbo, M. R.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Albert Einstein College of Medicine (US)
- North Carolina Central University (US)
- ORCID
- Venue
- Science
- Published
- 2010-11-05
- Volume
- 330
- Issue
- 6005
- Pages
- 831-835
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3110694
- OpenAlex
- W2140145798
- Cited by
- 1,080
- References
- 39
- Citations by year
- 2026: 97 · 2025: 80 · 2024: 103 · 2023: 101 · 2022: 92 · 2021: 92 · 2020: 100 · 2019: 82 · 2018: 70 · 2017: 67 · 2016: 47 · 2015: 33 · 2014: 34 · 2013: 28 · 2012: 29
- FWCI
- 25.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Damon Runyon Cancer Research Foundation
- Golden LEAF Foundation
- National Institutes of Health
- National Cancer Institute (CA 127231, R01CA161879, R01CA127231, CA98468, R01CA098468)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- irinotecan, chemotherapy-induced diarrhea, enzyme inhibitors, gut microbiota, commensal bacteria, substrate specificity, crystal structure, high-throughput screening, oral administration, colon cancer, drug toxicity
- MeSH terms
- Irinotecan, Animals, Antineoplastic Agents, Phytogenic, Bacteria, Anaerobic, Camptothecin, Colon, Diarrhea, Drug Evaluation, Preclinical, Enzyme Inhibitors, Escherichia coli, Female, Glucuronidase, Humans, Intestinal Mucosa, Mice, Inbred BALB C, Models, Molecular, Prodrugs, Protein Conformation, Crystallography, X-Ray, Escherichia coli Proteins, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.